6 assets in Central Nervous System Vasculitis

Therapeutic assets addressing Central Nervous System Vasculitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Central Nervous System Vasculitis	Fred Hutchinson Cancer Center	P2	CCC (53)
Camustine Central Nervous System Vasculitis	Fred Hutchinson Cancer Center	P2	CCC (53)
Cytarabine Central Nervous System Vasculitis	Fred Hutchinson Cancer Center	P2	CCC (53)
Etoposide Central Nervous System Vasculitis	Fred Hutchinson Cancer Center	P2	CCC (53)
Melphalan Central Nervous System Vasculitis	Fred Hutchinson Cancer Center	P2	CCC (53)
Prednisone Central Nervous System Vasculitis	Fred Hutchinson Cancer Center	P2	CCC (53)